Black Diamond Therapeutics BDTX
NASDAQ BDTX
$2.04 -0.03 (-1.45%)
As of: Oct 21, 2026 · 11:41 AM EDT

Black Diamond Therapeutics (BDTX) EBIT Margin (2025)

Updated

Black Diamond Therapeutics (BDTX) recorded EBIT Margin of 17.89% in FY2025.

Analysis

Black Diamond Therapeutics (BDTX) EBIT Margin (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 28.21%
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 37.86%
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn -3.52%
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 20.57%
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 34.95%
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn -133.21%
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 28.37%
10 Black Diamond Therapeutics 116.74 Mn -376.18 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 77.90%
API Access

Black Diamond Therapeutics EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=BDTX&period=max&api_key=YOUR_API_KEY